Preoperative (preop) chemosensitivity Testing as predictor of treatment benefit in adjuvant stade III colon cancer (CC) : Interim analysis of the PEPITA study

Hendlisz, Alain;Deleporte, Amélie;Van Laethem, Jean-Luc;Vergauwe, Philippe;Belgian Group for Digestive Oncology (BGDO);et.al.
(2014) 2014 ASCO GI Meeting — Location: (United States) San Francisco, CA (16.January.2014)

Files

No attached file found for this publication.

Details

Authors
  • Hendlisz, Alain
    Author
  • Deleporte, Amélie
    Author
  • Van Laethem, Jean-Luc
    Author
  • Vergauwe, Philippe
    Author
  • Van den Eynde, MarcUCLouvain
    Author
  • D'Hondt, LionelUCLouvain
    Author
  • Belgian Group for Digestive Oncology (BGDO)
    Collaborator
Show more
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Hendlisz, A., Deleporte, A., Van Laethem, J.-L., Vergauwe, P., Van den Eynde, M., Deboever, G., Janssens, J., Demolin, G., Holbrechts, S., Clausse, M., Vermeij, J., D’Hondt, L., Laurent, S., Efira, A., Gomez Galdon, M., Buggenhout, A., Garcia, C., Piccart-Gebhart, M. J., & Flamen, P. (2014). Preoperative (preop) chemosensitivity Testing as predictor of treatment benefit in adjuvant stade III colon cancer (CC) : Interim analysis of the PEPITA study. 2014 ASCO GI Meeting, (United States) San Francisco, CA. https://hdl.handle.net/2078.5/47093